Legend Biotech Q3 2026 Results: Turns Profitable, Net Income $51.7M
Legend Biotech reported a significant turnaround for Q3 2026, achieving a net income of $51.7 million compared to a net loss of $39.6 million in the prior year, driven by higher CARVYKTI collaboration revenue and lower R&D and administrative expenses. Total revenue grew to $359.5 million, and the company achieved an operating income of $46.8 million.
- Key figure
- Net income $51.7M